Rainbow Childrens Medicare working capital

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

55.63×	55.63×	48.26×	47.19×	38.72×	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
19.34×	19.34×	17.79×	18.12×	18.14×
153.97×	153.97×	161.48×	183.27×	194.83×
−79.00×	−79.00×	−95.43×	−117.96×	−137.97×
3.80×	3.56×	2.22×	2.75×	3.46×
0.66×	0.66×	0.67×	0.66×	0.76×
1.49×	1.49×	1.62×	1.47×	1.54×
0.77×	0.77×	0.81×	0.75×	0.83×

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

RAINBOW₹1,196.80

Rainbow Childrens Medicare Ltd.

· Pharma & Health

₹ CrorePeersAPOLLOHOSP FORTIS KIMS POLYMED PFIZER ONESOURCE JUBLPHARMA VIJAYAMcap ₹12,155 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Inventory Days (DIO)	38.72	47.19	48.26	55.63	55.63
Receivable Days (DSO)	18.14	18.12	17.79	19.34	19.34
Payable Days (DPO)	194.83	183.27	161.48	153.97	153.97
Cash Conversion Cycle (days)	-137.97	-117.96	-95.43	-79.00	-79.00
Working Capital Turnover	3.46	2.75	2.22	3.56	3.80
Asset Turnover	0.76	0.66	0.67	0.66	0.66
Cash Conversion (CFO/Net Income)	1.54	1.47	1.62	1.49	1.49
CFO/EBITDA	0.83	0.75	0.81	0.77	0.77

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.